A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
Clinical trial NCT00771667 · COMPLETED
Trial details
- NCT number
- NCT00771667
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-05-01
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.